S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
Log in

Isra Vision AG (ISR.F) Stock Forecast, Price & News

+0.20 (+0.42 %)
(As of 01/26/2021 12:00 AM ET)
Today's Range
Now: €47.34
50-Day Range
MA: €47.29
52-Week Range
Now: €47.34
Volume6,295 shs
Average VolumeN/A
Market Capitalization$1.04 billion
P/E Ratio78.77
Dividend Yield0.38%
As of June 24, 2020, Isra Vision AG operates as a subsidiary of Atlas Copco AB.
Isra Vision AG (ISR.F) logo


Overall MarketRank

0.97 out of 5 stars

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Software - Application
Phone49 6151 948 0
Year FoundedN/A



Sales & Book Value

Annual Sales$133.18 million
Cash Flow€1.51 per share
Book Value€9.86 per share



Market Cap$1.04 billion
Next Earnings DateN/A
OptionableNot Optionable
+0.20 (+0.42 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ISR News and Ratings via Email

Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Isra Vision AG (ISR.F) (ETR:ISR) Frequently Asked Questions

How has Isra Vision AG (ISR.F)'s stock price been impacted by COVID-19?

Isra Vision AG (ISR.F)'s stock was trading at €49.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ISR shares have decreased by 4.7% and is now trading at €47.34.
View which stocks have been most impacted by COVID-19

Is Isra Vision AG (ISR.F) a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Isra Vision AG (ISR.F) in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Isra Vision AG (ISR.F) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ISR, but not buy additional shares or sell existing shares.
View analyst ratings for Isra Vision AG (ISR.F)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Isra Vision AG (ISR.F)?

Wall Street analysts have given Isra Vision AG (ISR.F) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Isra Vision AG (ISR.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is Isra Vision AG (ISR.F) a good dividend stock?

Isra Vision AG (ISR.F) pays an annual dividend of €0.18 per share and currently has a dividend yield of 0.38%. The dividend payout ratio of Isra Vision AG (ISR.F) is 29.95%. This payout ratio is at a healthy, sustainable level, below 75%.
View Isra Vision AG (ISR.F)'s dividend history.

What price target have analysts set for ISR?

4 brokers have issued twelve-month target prices for Isra Vision AG (ISR.F)'s stock. Their forecasts range from €43.00 to €50.00. On average, they expect Isra Vision AG (ISR.F)'s share price to reach €48.25 in the next year. This suggests a possible upside of 1.9% from the stock's current price.
View analysts' price targets for Isra Vision AG (ISR.F)
or view Wall Street analyst' top-rated stocks.

Who are some of Isra Vision AG (ISR.F)'s key competitors?

What other stocks do shareholders of Isra Vision AG (ISR.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Isra Vision AG (ISR.F) investors own include Palo Alto Networks (PANW), Alnylam Pharmaceuticals (ALNY), Arcturus Therapeutics (ARCT), Broadcom (AVGO), Alteryx (AYX), Bio-Rad Laboratories (BIO), Compugen (CGEN), Editas Medicine (EDIT), Gilead Sciences (GILD) and Illumina (ILMN).

Who are Isra Vision AG (ISR.F)'s key executives?

Isra Vision AG (ISR.F)'s management team includes the following people:
  • Mr. Enis Ersü, Founder, Chairman of Exec. Management Board & CEO
  • Mr. Hans Jürgen Christ, Deputy Chairman of Exec. Management Board & Head of Sales
  • Dr. Johannes Giet, Head of R&D and Member of Exec. Management Board
  • Dr. Frank Meyer, Member of Exec. Management Board
  • Mr. Martin Heinrich, Member of Exec. Management Board
  • Mr. Tomas Lundin, Member of Exec. Management Board

What is Isra Vision AG (ISR.F)'s stock symbol?

Isra Vision AG (ISR.F) trades on the ETR under the ticker symbol "ISR."

What is Isra Vision AG (ISR.F)'s stock price today?

One share of ISR stock can currently be purchased for approximately €47.34.

How big of a company is Isra Vision AG (ISR.F)?

Isra Vision AG (ISR.F) has a market capitalization of $1.04 billion and generates $133.18 million in revenue each year. Isra Vision AG (ISR.F) employs 841 workers across the globe.

What is Isra Vision AG (ISR.F)'s official website?

The official website for Isra Vision AG (ISR.F) is www.isravision.com.

How can I contact Isra Vision AG (ISR.F)?

The company can be reached via phone at 49 6151 948 0.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.